Basic Principles of Drug Discovery and Development, Third Edition presents a unique overview of the drug discovery and development program not available elsewhere. Each chapter provides sufficient technical details on the topics covered so that non-experts will have the tools and information necessary to interact and exchange information with colleagues across the entire spectrum of the drug discovery and development process. The drug discovery and development process involves individuals and teams with a wide array of expertise ranging from basic sciences (medicinal chemistry, biology) to applied science (pharmacology, pharmacokinetics, clinical sciences) to business driven fields (regulatory affairs, intellectual property experts, marketing specialists). The success or failure of a program focused on bringing a new medication to market often depends on clear communication between individuals and teams with vastly different expertise. As a result, it is critical that experts in one aspect of drug discovery and development (e.g., medicinal chemists) have a working understanding of the wide range of disciplines that take part in the overall process. Provides a clear explanation of how the pharmaceutical industry works, as well as the complete drug discovery process, from obtaining a lead, to testing the bioactivity, to producing the drug, and protecting the intellectual property - Includes a new chapter on the discovery and development of biologics (antibodies proteins, antibody/receptor complexes, antibody drug conjugates), a growing and important area of the pharmaceutical industry landscape - Features a new section on formulations, including a discussion of IV formulations suitable for human clinical trials, as well as the application of nanotechnology and the use of transdermal patch technology for drug delivery - Includes new case studies with additional modern examples of drug discovery using high through-put screening, fragment-based drug design, and computational chemistry, as well as studies on the development of biologics Presents the multidisciplinary process of identifying a new drug, including perspectives from medicinal chemists, biologists, pharmacologists, drug metabolism experts, toxicologists, and clinicians The drug discovery and development process involves individuals and teams with a wide array of expertise ranging from basic sciences (medicinal chemistry, biology) to applied science (pharmacology, pharmacokinetics, clinical sciences) to business driven fields (regulatory affairs, intellectual property experts, marketing specialists). The success or failure of a program focused on bringing a new medication to market often depends on clear communication between individuals and teams with vastly different expertise. As a result, it is critical that experts in one aspect of drug discovery and development (e.g. medicinal chemists) have at minimum a working understanding of the wide range of disciplines that take part in the overall process. The various field of science associated with drug discovery and development are constantly evolving. New technologies and methods become available on a regular basis, previously unknown biological targets are routinely discovered, and as the world discovered with COVID‐19, nature creates potential threats to human health at unpredictable moments. Scientist must keep up with these changes and students interested in the various scientific disciplines associated with drug discovery and development must be provide with up to date resource material. As a result of this need, textbooks that cover drug discovery and development must be routinely updated in order to stay relevant. Basic Principles of Drug Discovery and Development must be updated to maintain its position as a primary teaching tool and reference text for the next generation of scientists. This book provides the reader with a unique overview of the drug discovery and development program not available elsewhere. Each chapter provides sufficient technical details on the topics covered such that non-experts in a field will have the tools and information necessary to interact with and exchange information with colleagues across the entire spectrum of the drug discovery and development process. As an industrial medicinal chemist, Dr. Blass has experience with major pharmaceutical organizations (Wyeth, Procter & Gamble Pharmaceuticals) and small biotech operations (Fox Chase Chemical Diversity Center), which provided him with a wealth of expertise in the art of drug discovery and development (including a wide range of disease states and biological targets). His position with Temple University’s School of Pharmacy and the Moulder Center for Drug Discovery has provided him with essential experience as an educator and academic scientist. These experiences, as well as his training and expertise as a registered US patent agent, have provided him with the tools and skills necessary to bridge the gap betwe